These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 1326962)
1. Analysis of binding protein for tissue-type plasminogen activator in human endothelial cells. Fukao H; Hagiya Y; Nonaka T; Okada K; Matsuo O Biochem Biophys Res Commun; 1992 Sep; 187(2):956-62. PubMed ID: 1326962 [TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase. Hajjar KA; Hamel NM J Biol Chem; 1990 Feb; 265(5):2908-16. PubMed ID: 2154465 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of tissue-type plasminogen activator (t-PA) activity by purified t-PA receptor expressed in human endothelial cells. Fukao H; Ueshima S; Takaishi T; Okada K; Matsuo O Biochim Biophys Acta; 1997 Mar; 1356(1):111-20. PubMed ID: 9099997 [TBL] [Abstract][Full Text] [Related]
4. Interaction of wild-type and catalytically inactive mutant forms of tissue-type plasminogen activator with human umbilical vein endothelial cell monolayers. Ramakrishnan V; Sinicropi DV; Dere R; Darbonne WC; Bechtol KB; Baker JB J Biol Chem; 1990 Feb; 265(5):2755-62. PubMed ID: 2105933 [TBL] [Abstract][Full Text] [Related]
5. Interaction of tissue plasminogen activator with a human endothelial cell 45-kilodalton plasminogen receptor. Dudani AK; Pluskota A; Ganz PR Biochem Cell Biol; 1994; 72(3-4):126-31. PubMed ID: 7818846 [TBL] [Abstract][Full Text] [Related]
6. Binding of mutant tissue-type plasminogen activators to human endothelial cells and their extracellular matrix. Fukao H; Ueshima S; Okada K; Matsuo O Life Sci; 2000; 66(25):2473-87. PubMed ID: 10894090 [TBL] [Abstract][Full Text] [Related]
7. The endothelial cell tissue plasminogen activator receptor. Specific interaction with plasminogen. Hajjar KA J Biol Chem; 1991 Nov; 266(32):21962-70. PubMed ID: 1657983 [TBL] [Abstract][Full Text] [Related]
8. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells. Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828 [TBL] [Abstract][Full Text] [Related]
9. The interaction of recombinant tissue type plasminogen activator and recombinant plasminogen activator (r-PA/BM 06.022) with human endothelial cells. Mulder M; Kohnert U; Fischer S; van Hinsbergh VW; Verheijen JH Blood Coagul Fibrinolysis; 1997 Mar; 8(2):124-33. PubMed ID: 9518044 [TBL] [Abstract][Full Text] [Related]
10. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator. Schleef RR; Podor TJ; Dunne E; Mimuro J; Loskutoff DJ J Cell Biol; 1990 Jan; 110(1):155-63. PubMed ID: 2104856 [TBL] [Abstract][Full Text] [Related]
11. Characterization of tissue plasminogen activator binding proteins isolated from endothelial cells and other cell types. Beebe DP; Wood LL; Moos M Thromb Res; 1990 Jul; 59(2):339-50. PubMed ID: 2122540 [TBL] [Abstract][Full Text] [Related]
12. Identification and partial characterization by chemical cross-linking of a binding protein for tissue-type plasminogen activator (t-PA) on rat hepatoma cells. A plasminogen activator inhibitor type 1-independent t-PA receptor. Bu G; Morton PA; Schwartz AL J Biol Chem; 1992 Aug; 267(22):15595-602. PubMed ID: 1322401 [TBL] [Abstract][Full Text] [Related]
13. Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand. Cheng XF; Bäck O; Nilsson TK; Nylander Lundqvist E; Pohl G; Wallén P Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):407-13. PubMed ID: 1332673 [TBL] [Abstract][Full Text] [Related]
14. Urokinase binding and receptor identification in cultured endothelial cells. Haddock RC; Spell ML; Baker CD; Grammer JR; Parks JM; Speidel M; Booyse FM J Biol Chem; 1991 Nov; 266(32):21466-73. PubMed ID: 1657968 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA. Otter M; Kuiper J; Bos R; Rijken DC; van Berkel TJ Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):545-50. PubMed ID: 1318035 [TBL] [Abstract][Full Text] [Related]
17. Analysis of tissue-type plasminogen activator receptor (t-PAR) in human endothelial cells. Fukao H; Matsuo O Semin Thromb Hemost; 1998; 24(3):269-73. PubMed ID: 9701459 [TBL] [Abstract][Full Text] [Related]
18. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator. Sitter T; Toet K; Quax P; Kooistra T Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120 [TBL] [Abstract][Full Text] [Related]
19. Demonstration of a specific clearance receptor for tissue-type plasminogen activator on rat Novikoff hepatoma cells. Nguyen G; Self SJ; Camani C; Kruithof EK J Biol Chem; 1992 Mar; 267(9):6249-56. PubMed ID: 1313432 [TBL] [Abstract][Full Text] [Related]
20. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects. Bikfalvi A; Sauzeau C; Moukadiri H; Maclouf J; Busso N; Bryckaert M; Plouet J; Tobelem G J Cell Physiol; 1991 Oct; 149(1):50-9. PubMed ID: 1719003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]